Filter by
Filter by
Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy.
Published in the Green Journal, this survey study sent to 19 European PT centers revealed wide variations in planning approach and consequently dose to organs...
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
This study identified two risk factors associated with severe hearing loss (HL) in children with medulloblastoma treated with PSPT, which are patient age <7...
Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma.
This study included 79 with newly diagnosed medulloblastoma treated with craniospinal RT in order to evaluate the effect of lymphopenia during RT. Eighty-three...
Empowering Cancer Care with Proton Therapy
This webinar provides invaluable insights from the leading experts sharing their expertise on the clinical benefits of Proton Therapy compared to conventional...